TABLE 1

Data for Individual Patients and SUVs for ¹⁸F-FDG and ¹⁸F-FET in Primary Lesions

Patient no.	Sex	Age (y)	Histologic type	Stage	Location	Size (cm)	¹⁸F-FDG SUV	¹⁸F-FET SUV
1	M	52	SCC	pT1 N0	Oral cavity	0.7 in 4.3 ulcer	5.2	1.5
2	M	64	SCC	pT2 N0	Oral cavity	2.5	21.5	4.0
3	M	45	SCC	pT2 N2c	Oral cavity	4.0	14.8	3.5
4	M	59	SCC	pT2 N2b	Oral cavity	3.5	12.0	4.0
5	M	51	SCC	pT2 N1	Oropharynx	6.1	8.4	2.8
			SCC	pT4b N1	Oral cavity	1.8	7.5	2.8
6	M	60	SCC	pT3 N0	Parotid gland	5.4	17.8	7.2
7	M	47	SCC	pT2 N0	Maxillary sinus	2.5	7.7	4.3
8	M	41	SCC	pT2 N0	Oral cavity	2.5	10.4	3.7
9	M	79	SCC	pT4a N0	Oral cavity	2.5	44.3	8.7
10	F	48	SCC	pT1 N0	Oral cavity	0.8	4.4	2.7
11	M	68	SCC	pT2 N0	Oral cavity	3.2	14.3	4.3
12	M	72	SCC	pT2 N1	Oral cavity	3.5	8.0	3.6
13	M	80	Inflammation		Oral cavity	3.0	3.7	1.6
14	M	63	SCC	pT3 N0	Oropharynx	8.0	21.5	5.0
			SCC	pT2 N0	Hypopharynx	2.7	8.0	3.8
15	F	74	SCC	pT1 N0	Oral cavity	0.3	1.8	0.9
16	M	49	Inflammation		Oropharynx	1.0	4.0	1.4
17	M	68	SCC	pT4 N0	Oral cavity	4.5	7.4	3.3
18	M	73	SCC	pT2 N0	Oral cavity	3.5	11.7	9.2
19	M	74	SCC	pT1 N0	Oral cavity	1.8	11.6	4.8
20	M	50	Inflammation		Oral cavity	1.2	4.7	1.3
21	F	73	SCC	pT3 N0	Oral cavity	8.3	20.7	7.4